Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Michael Hur"'
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81405 (2013)
Three members of a family of small neurotoxic peptides from the venom of Conus parius, conantokins (Con) Pr1, Pr2, and Pr3, function as antagonists of N-methyl-D-aspartate receptors (NMDAR). We report structural characterizations of these synthetic p
Externí odkaz:
https://doaj.org/article/242d700ab10c4b8fa33b63aa9acd145b
Publikováno v:
Pilot and Feasibility Studies, Vol 10, Iss 1, Pp 1-23 (2024)
Abstract Background Chronic pain is reported by between 30 and 71% of people with haemophilia (PWH). Exercise is shown to be effective for pain management in other arthritides, but it remains unclear if such an approach is effective or acceptable to
Externí odkaz:
https://doaj.org/article/c2428099aee840c49bf674d2086a742f
Autor:
Johannes Uhlig, Annemarie Uhlig, Hari Deshpande, Philipp Ströbel, Lutz Trojan, Joachim Lotz, Michael Hurwitz, Omeed Hafez, Peter Humphrey, Viktor Grünwald, Hyun S. Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract To assess epidemiology, clinical presentation, treatment and overall survival of adult patients with renal sarcomas, the 2004–2016 SEER and NCDB databases were queried for adult patients diagnosed with renal sarcoma, calculating average an
Externí odkaz:
https://doaj.org/article/c8363869872047e39dfe581fdc99fe18
Autor:
Michael Hur, Ki Hoon, author
Publikováno v:
Making Identity Count : Building a National Identity Database, 2016.
Externí odkaz:
https://doi.org/10.1093/acprof:oso/9780190255473.003.0011
Autor:
Kevin G. Pollock, Carissa Dickerson, Manjit Kainth, Sarah Lawton, Michael Hurst, Daniel M. Sugrue, Chris Arden, D. Wyn Davies, Anne-Céline Martin, Belinda Sandler, Jason Gordon, Usman Farooqui, David Clifton, Christian Mallen, Jennifer Rogers, Nathan R. Hill, A. John Camm, Alexander T. Cohen
Publikováno v:
BMC Primary Care, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Conducting effective and translational research can be challenging and few trials undertake formal reflection exercises and disseminate learnings from them. Following completion of our multicentre randomised controlled trial, whic
Externí odkaz:
https://doaj.org/article/27c52a2dc0a040fbb3abfb3cdcb472c8
Autor:
Rebeccah Slater, Christopher Eccleston, Amanda Williams, Katy Vincent, Mattias Linde, Michael Hurley, William Laughey
Publikováno v:
PAIN Reports, Vol 9, Iss 3, p e1161 (2024)
Externí odkaz:
https://doaj.org/article/1b06d08cee3d486eaa0f515e30c9a58c
Autor:
Michael Hurwitz, Mark Stein, Jeffrey Sosman, David F McDermott, Michael B Atkins, Naomi B Haas, Elizabeth R Plimack, Hans Hammers, Mehmet A Bilen, Meredith M Regan, Moshe C Ornstein, David Einstein, Opeyemi A Jegede, Robert Alter, David J Peace, Paul J Catalano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background As part of a partitioned survival analysis, treatment-free survival (TFS) can characterize the overall survival time patients spend between the cessation of immunotherapy and the start of subsequent therapy; both with and without toxicity.
Externí odkaz:
https://doaj.org/article/23ac543db705415f93126b90c7cd9853
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Improved approaches for chronic pain management are a clinical and research priority for people with haemophilia (PWH). Involving people with lived experience in the design of a complex rehabilitation intervention strengthens the
Externí odkaz:
https://doaj.org/article/8c3aa7de440b4ce28caff01dbc0c04b4
Autor:
Dijana Djureinovic, Sarah A. Weiss, Irina Krykbaeva, Rihao Qu, Ioannis Vathiotis, Myrto Moutafi, Lin Zhang, Ana L. Perdigoto, Wei Wei, Gail Anderson, William Damsky, Michael Hurwitz, Barbara Johnson, David Schoenfeld, Amit Mahajan, Frank Hsu, Kathryn Miller-Jensen, Yuval Kluger, Mario Sznol, Susan M. Kaech, Marcus Bosenberg, Lucia B. Jilaveanu, Harriet M. Kluger
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background Stimulating inflammatory tumor associated macrophages can overcome resistance to PD-(L)1 blockade. We previously conducted a phase I trial of cabiralizumab (anti-CSF1R), sotigalimab (CD40-agonist) and nivolumab. Our current purpos
Externí odkaz:
https://doaj.org/article/4fa1a648e79343f59ea5d04accc2e62b
Autor:
Johannes Uhlig, Annemarie Uhlig, Hari Deshpande, Philipp Ströbel, Lutz Trojan, Joachim Lotz, Michael Hurwitz, Omeed Hafez, Peter Humphrey, Viktor Grünwald, Hyun S. Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/795866daa23f417e9ad257685928d792